Bright Minds Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DRUG and other ETFs, options, and stocks.About DRUG
Bright Minds Biosciences, Inc. is a biotechnology company, which engages in the development of therapeutics. The company was founded by Ian B.
CEOIan B. McDonald
CEOIan B. McDonald
Employees—
Employees—
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2019
Founded2019
Employees—
Employees—
DRUG Key Statistics
Market cap664.05M
Market cap664.05M
Price-Earnings ratio-90.51
Price-Earnings ratio-90.51
Dividend yield—
Dividend yield—
Average volume163.73K
Average volume163.73K
High today$88.00
High today$88.00
Low today$84.85
Low today$84.85
Open price$85.05
Open price$85.05
Volume114.77K
Volume114.77K
52 Week high$93.40
52 Week high$93.40
52 Week low$23.18
52 Week low$23.18
Stock Snapshot
The current Bright Minds Biosciences(DRUG) stock price is $85.67, with a market capitalization of 664.05M. The stock trades at a price-to-earnings (P/E) ratio of -90.51.
During the trading session on 2025-12-15, Bright Minds Biosciences(DRUG) shares reached a daily high of $88.00 and a low of $84.85. At a current price of $85.67, the stock is +1.0% higher than the low and still -2.6% under the high.
Trading activity shows a volume of 114.77K, compared to an average daily volume of 163.73K.
The stock's 52-week range extends from a low of $23.18 to a high of $93.40.
The stock's 52-week range extends from a low of $23.18 to a high of $93.40.
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own DRUG. This list is generated using Robinhood data, and it’s not a recommendation.